U.S. Banks Stock News

NYSE:LNN
NYSE:LNNMachinery

Lindsay (LNN) Stock May Be 28% Undervalued On Cash Flow

Lindsay stock presents a mixed picture on valuation today. The Discounted Cash Flow (DCF) intrinsic value estimate points to upside relative to the market price, while the earnings multiples suggest the shares trade at a richer level than the fundamentals may justify. Over the past 5 years the share price has fallen 26.8%, which points to weak long term returns for investors who have held through that period. Future cash flow growth and margin quality in Lindsay's irrigation and...
NasdaqGS:STBA
NasdaqGS:STBABanks

S&T Bancorp (STBA) Stock Looks Like A Bargain On Returns Yet Full On Earnings

S&T Bancorp stock has more than doubled over the past five years, yet the current valuation checks send mixed signals. The Excess Returns intrinsic value estimate points to a meaningful discount to fair value, while market based multiples suggest the shares trade on the rich side. Over the past 5 years S&T Bancorp has returned 102.2%, which puts extra attention on whether today’s price still leaves room for attractive long term returns. For a regional bank, the strength and consistency of...
NYSE:KAI
NYSE:KAIMachinery

Kadant (KAI) Stock May Be Fully Priced Despite Its 48% Run

Kadant stock has delivered a solid 5 year return, yet the valuation picture today is more balanced, with the intrinsic value estimate sitting close to the current share price while traditional market multiples lean rich. For investors looking at Kadant now, the question is less about past gains and more about whether the current price fairly reflects its future cash flow potential. Over the past 5 years, Kadant has returned about 48.4%, which suggests the market has already priced in a...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) Could Be 9% Undervalued Following Court Sanctions And Legal Risk Questions

A California Workers' Compensation Appeals Board judge recently sanctioned Lyft (LYFT) for willfully delaying discovery and acting with malice in a catastrophic driver injury case, sharpening investor focus on its gig worker classification model. Lyft shares trade at US$17.65 and have shown strong near term momentum, with a 30 day share price return of 24.3% and a 90 day return of 28.83%. However, the year to date share price return is down 10.81% and the 5 year total shareholder return is...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

MYR Group (MYRG) Dropped, So What Is Driving Attention Now?

Oversold signal puts MYR Group stock on traders’ radar MYR Group (MYRG) recently declined 17.3% over the past month, pushing its Relative Strength Index to 29.24, which is commonly viewed as oversold and is now drawing closer attention from short term traders. Over the past few months, MYR Group’s share price has shifted from strong year to date momentum, with a 30.62% share price return, to a sharp pullback, including a 21.90% decline over 30 days and 37.26% over 90 days. Even so, the 1 year...
NYSE:GNK
NYSE:GNKShipping

Genco Shipping & Trading (GNK) Stock Still Looks Stretched On New Vessel Delivery

Genco Shipping & Trading stock has delivered very strong returns over the past few years, while current valuation checks suggest the shares are not a clear bargain at recent prices. The company’s expansion and income-focused messaging sit alongside a low overall value score and an overvalued read on standard market multiples. Genco Shipping & Trading has returned about 143.3% over the past 3 years, which puts added pressure on today’s buyers to justify the current share price. The recent...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Stock Looks Rich On Book Value While Returns Stay Strong

Denali Therapeutics stock has delivered a strong 60.3% return over the past year, while the broader valuation checks currently lean towards the shares looking expensive rather than like a clear bargain. The 60.3% one year gain highlights how much optimism has been priced into Denali Therapeutics in a relatively short period. Expectations for the company to convert its drug development pipeline into sustainable revenue can support the current share price, although uncertainty around clinical...
NYSE:IOT
NYSE:IOTSoftware

Samsara (IOT) Stock Looks Fully Priced With Strong Cash Flow And Rich Sales

Samsara has delivered a 3 year gain that is well ahead of many mature software peers, yet current valuation checks suggest the stock is trading at a premium to its intrinsic value estimate. Both the Discounted Cash Flow (DCF) view and market multiples currently point to Samsara stock leaning expensive rather than offering an obvious margin of safety. Samsara has returned about 51.0% over 3 years, which means recent shareholders have already captured a substantial part of the story the market...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Tractor Supply (TSCO) Stock May Be 12% Below Fair Value On Cash Flow

Tractor Supply stock has seen a steep share price decline over the past year, yet a fresh Discounted Cash Flow (DCF) intrinsic value estimate suggests the current market price may sit below what the company’s projected cash flows could justify, while broader valuation checks look more mixed than clearly cheap. The share price is down 41.3% over the past year, which puts the current valuation under closer scrutiny after a long stretch of weaker returns. Future cash generation from Tractor...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Should Opera’s Raised 2026 AI‑Driven Revenue Guidance Require Action From Opera (OPRA) Investors?

In August 2026, Opera Limited reported past second-quarter results showing sales of US$178.07 million and net income of US$27.55 million, alongside higher earnings per share versus a year earlier. On the same day, Opera raised its third-quarter and full-year 2026 revenue guidance, highlighting confidence in AI-enabled products and fintech monetization as key earnings drivers. We will examine how Opera’s raised 2026 guidance, underpinned by AI-enabled product monetization, shapes the...
NasdaqGS:ALGT
NasdaqGS:ALGTAirlines

Is Allegiant Travel (ALGT) Undervalued Following The Raymond James Upgrade?

Allegiant Travel (ALGT) drew investor attention after Raymond James upgraded the stock while cutting estimates across the broader airline group, citing higher jet fuel forecasts as well as Allegiant specific margin recovery and capacity flexibility factors. At a share price of $82.32, Allegiant Travel has seen a modest 1-day share price return of 0.85%, while the 30-day share price return is down 16.07% and the year-to-date share price return is down 6.47%. The 1-year total shareholder return...
NYSE:SWK
NYSE:SWKMachinery

Stanley Black & Decker (SWK), What Is Behind The Fresh Attention?

Stanley Black & Decker (SWK) has announced plans to invest US$1b in the U.S. through 2028, targeting next-generation tools, manufacturing capacity, and skilled trades training. This initiative could reshape how investors think about the stock. Over the past year, Stanley Black & Decker has seen stronger momentum, with a 30-day share price return of 7.89% and a 90-day share price return of 23.91%. The 1-year total shareholder return of 36.92% contrasts with a 5-year total shareholder return...
NYSE:AXP
NYSE:AXPConsumer Finance

Is American Express (AXP) Undervalued Following Its Card Expansion And St Andrews Partnership?

American Express (AXP) is back on investors’ radar after the board declared a dividend on its 6.450% Fixed Rate Reset Noncumulative Preferred Shares, Series E, alongside fresh product and partnership announcements. Over the past few weeks, American Express has combined headlines around the St Andrews Links partnership, expanded virtual card capabilities, and this preferred dividend with steady share price momentum. This includes a 30 day share price return of 3% and a 90 day share price...
NYSE:MMM
NYSE:MMMIndustrials

3M (MMM) Could Be 1% Undervalued On Its New Dividend Declaration

3M (MMM) recently declared a third quarter 2026 dividend of $0.78 per share, payable on September 11 to shareholders of record on August 24. This dividend decision offers a fresh reference point for assessing the stock. 3M's latest dividend decision comes as the share price trades at $179.37, with a 90 day share price return of 15.60% and a 1 year total shareholder return of 16.68%. This suggests recent momentum has been stronger than the longer term 5 year total shareholder return of...
NYSE:NET
NYSE:NETIT

Cybersecurity Stocks Retail Investors Are Watching After The U.S. Breach

A sweeping cyber intrusion into key U.S. institutions has turned cybersecurity stocks into a focal point, as investors reassess how exposed companies are to state-backed hackers and critical infrastructure risks. This shock to confidence can also be a source of opportunity, especially for stocks seen as part of the solution. This article introduces three cybersecurity stocks from our screener that appear positively exposed to this news and explains why each one matters now. The stocks covered...
NYSE:JBL
NYSE:JBLElectronic

Is Jabil (JBL) Undervalued Following Its Latest Pullback?

Recent trading move puts Jabil in focus Jabil (JBL) has drawn fresh attention after a 2.66% decline in its latest trading session, which left the stock lagging the broader market and prompted investors to reassess expectations ahead of upcoming earnings. At a share price of $308.68, Jabil has pulled back over the past week and quarter, with the 7-day and 90-day share price returns down 8.84% and 16.88%. However, the year-to-date share price return of 28.41% and 1-year total shareholder return...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

The Bull Case For Enphase Energy (ENPH) Could Change Following AI-Driven Platform And European Expansion Moves

In August 2026, Enphase Energy introduced an AI Assistant in its app for homeowners, opened U.S. pre-orders for its first commercial-scale IQ Battery C80 storage system, and expanded its integrated solar, storage, backup, and EV charging platform into Italy while ramping homeowner outreach and financing support in the Netherlands. Together, these moves show Enphase pushing beyond hardware into AI-enabled home energy management and larger commercial storage, while tailoring offerings to...
NYSE:HLT
NYSE:HLTHospitality

Hilton (HLT) Stock Looks Fully Priced Despite Its 167% Five Year Run

Hilton Worldwide Holdings has delivered very strong gains over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently indicate the stock trades at a premium to those fundamentals. With the DCF pointing to an overvalued reading and a broad value score of zero, investors are weighing a strong share price history against signals that suggest limited margin of safety at recent levels. Hilton Worldwide Holdings has returned about...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton (DHI) Stock May Be A Bargain Despite Mold Lawsuit Pressure

D.R. Horton stock has delivered a 66.1% total return over five years, yet current valuation checks suggest the shares may still trade below an intrinsic value estimate from a Discounted Cash Flow (DCF) approach and also screen as undervalued on earnings multiples. At the same time, a mixed overall value score and rising legal and construction cost pressures keep the picture more balanced than the headline upside might suggest. The 66.1% return over five years points to solid long term...
NYSE:HR
NYSE:HRHealth Care REITs

Kraft Heinz Stock And 2 High Dividend Shares Worth A Closer Look

Long term Treasury yields are back near early 2000s levels, policy makers are arguing in public, and investors are questioning whether US government bonds still feel like the default safe anchor. That mix is pushing more attention onto established large caps that already return cash to shareholders. This article looks at three stocks from our value and high dividend screener that appear particularly exposed to these bond market crosswinds. The stocks covered below are just a starting sample...
NYSE:VVV
NYSE:VVVSpecialty Retail

Has Valvoline (VVV) Fallen Enough To Look Fairly Valued?

Valvoline stock has fallen 16.3% over the past year even as recent valuation checks suggest the shares are roughly in line with fair value rather than a clear bargain. That mix of weaker recent returns and an unremarkable overall value profile puts the focus on what is already reflected in the price. The 16.3% share price decline over 1 year signals that expectations have cooled even though the business continues to attract attention from investors. Recent store sales milestones and ongoing...
NYSE:O
NYSE:ORetail REITs

Realty Income (O) Stock Could Trade At A Discount On Cash Flow While Earnings Look Rich

Realty Income has delivered a 31.5% return over the past 3 years, yet its valuation signals are split, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to meaningful undervaluation while market based multiples look comparatively full and the broader value score is weak. A 31.5% gain over 3 years suggests Realty Income has rewarded patient shareholders, which makes the current valuation debate more important for new money. Recent issuance of US$1.625b in...
NYSE:CMP
NYSE:CMPMetals and Mining

Tariffs Are Reshaping Building Supply Chains and These U.S. Material Stocks Stand To Benefit

Escalating U.S. tariffs on Canadian materials and fresh Canadian retaliation are reshaping where North America gets its lumber, cement, and other building staples. That disruption can shift demand toward U.S. Domestic Substitutes for Canadian Industrial & Building Materials and away from others. This article unpacks that story and walks through three stocks exposed to this trade shock so you can judge whether they belong on your watchlist or not. The stocks covered below are just a starting...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Should FDA Fast Track for ERAS-0015’s Pan-RAS Glue Require Action From Erasca (ERAS) Investors?

Erasca, Inc. recently reported that the FDA granted Fast Track Designation to ERAS-0015, an oral pan-RAS molecular glue, for treating patients with metastatic pancreatic adenocarcinoma, following encouraging Phase 1 data in RAS-mutant solid tumors. An interesting angle for investors is that ERAS-0015’s pan-RAS design aims to address resistance by targeting both mutant and wildtype RAS variants, potentially broadening its clinical relevance across multiple tumor types. We’ll now examine how...